Healthcare

Sonida Senior Living operates senior housing communities and is riding favorable aging-population demand. Revenue has expanded quickly through occupancy gains and portfolio growth, making the company notable for readers following healthcare operators with visible operating momentum.

Surgery Partners runs outpatient surgical facilities in a part of healthcare with durable demand drivers. Revenue has climbed steadily and cash generation has improved, making the company notable for its exposure to the ongoing shift from hospital-based to lower-cost surgical care.

Septerna is a clinical-stage biotech building small-molecule medicines for hard-to-drug GPCR targets. Revenue is rising through partnerships, cash flow has improved sharply, and low debt adds flexibility, making its platform progress worth a closer look.

Ultragenyx develops medicines for rare genetic diseases and already has several marketed products generating meaningful revenue. What keeps it compelling is the mix of commercial scale, orphan-disease expertise, and multiple pipeline programs that could reshape the business over time.

Rapport Therapeutics is building targeted medicines for brain disorders, a field with major unmet need and large market potential. The recent rise in market interest reflects growing attention on its pipeline, selective science, and the possibility of meaningful clinical milestones ahead.